UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response

Journal of allergy and clinical immunology, 2014-08, Vol.134 (2), p.362-372

2014

Link zum Volltext

Verfügbarkeit prüfen

Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities

Journal of allergy and clinical immunology, 2011-04, Vol.127 (4), p.954-964.e4

2011

Link zum Volltext

Verfügbarkeit prüfen

Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

Journal of allergy and clinical immunology, 2012-12, Vol.130 (6), p.1344-1354

2012

Link zum Volltext

Verfügbarkeit prüfen

Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis

PloS one, 2012-04, Vol.7 (4), p.e35069-e35069

2012

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Journal of allergy and clinical immunology, 2014-12, Vol.134 (6), p.1293-1300

2014

Link zum Volltext

Verfügbarkeit prüfen

Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis

Journal of allergy and clinical immunology, 2009-12, Vol.124 (6), p.1235-1244.e58

2009

Link zum Volltext

Verfügbarkeit prüfen

IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model

PloS one, 2014-02, Vol.9 (2), p.e90284-e90284

2014

Link zum Volltext

Verfügbarkeit prüfen

TNF-α Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-α Antagonists to Improve Skin Barrier

Journal of investigative dermatology, 2011-06, Vol.131 (6), p.1272-1279

2011

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology

Journal of allergy and clinical immunology, 2014-06, Vol.133 (6), p.1626-1634

2014

Link zum Volltext

Verfügbarkeit prüfen

Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis

The Journal of immunology (1950), 2008-11, Vol.181 (10), p.7420-7427

2008

Link zum Volltext

Verfügbarkeit prüfen

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response

Journal of allergy and clinical immunology, 2011-09, Vol.128 (3), p.583-593.e4

2011

Link zum Volltext

Verfügbarkeit prüfen

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes

Journal of allergy and clinical immunology, 2009-11, Vol.124 (5), p.1022-1030.e395

2009

Link zum Volltext

Verfügbarkeit prüfen

The Human Cutaneous Squamous Cell Carcinoma Microenvironment Is Characterized by Increased Lymphatic Density and Enhanced Expression of Macrophage-Derived VEGF-C

Journal of investigative dermatology, 2011-01, Vol.131 (1), p.229-236

2011

Link zum Volltext

Verfügbarkeit prüfen

TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques

The Journal of immunology (1950), 2005-08, Vol.175 (4), p.2721-2729

2005

Link zum Volltext

Verfügbarkeit prüfen

Increase in TNF-α and Inducible Nitric Oxide Synthase-Expressing Dendritic Cells in Psoriasis and Reduction with Efalizumab (Anti-CD11a)

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (52), p.19057-19062

2005

Link zum Volltext

Verfügbarkeit prüfen

Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets

Journal of allergy and clinical immunology, 2011-09, Vol.128 (3), p.574-582.e12

2011

Link zum Volltext

Verfügbarkeit prüfen

Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis

Journal of allergy and clinical immunology, 2007-05, Vol.119 (5), p.1210-1217

2007

Link zum Volltext

Verfügbarkeit prüfen

Alefacept Reduces Infiltrating T Cells, Activated Dendritic Cells, and Inflammatory Genes in Psoriasis Vulgaris

Proceedings of the National Academy of Sciences - PNAS, 2005-02, Vol.102 (6), p.2075-2080

2005

Link zum Volltext

Verfügbarkeit prüfen

Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.577-579

2013

Link zum Volltext

Verfügbarkeit prüfen

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

Journal of allergy and clinical immunology, 2014-10, Vol.134 (4), p.955-957

2014

Link zum Volltext

Verfügbarkeit prüfen

Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects

Journal of investigative dermatology, 2006-07, Vol.126 (7), p.1590-1599

2006

Link zum Volltext

Verfügbarkeit prüfen

Atopic dermatitis keratinocytes exhibit normal TH17 cytokine responses

Journal of allergy and clinical immunology, 2010-03, Vol.125 (3), p.744-746.e2

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of Etanercept Are Distinct from Infliximab in Modulating Proinflammatory Genes in Activated Human Leukocytes

The Journal of investigative dermatology symposium proceedings, 2007-05, Vol.12 (1), p.9-15

2007

Link zum Volltext

Verfügbarkeit prüfen

Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis

Journal of translational medicine, 2007-06, Vol.5 (1), p.27-27, Article 27

2007

Link zum Volltext

Verfügbarkeit prüfen

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

Journal of allergy and clinical immunology, 2012-12, Vol.130 (6), p.1344-1354

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(72)

Sprache

Englisch
(72)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(47)
Science & Technology
(44)
Life Sciences & Biomedicine
(37)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Dermatology
(24)
Immunology
(24)
Female
(23)
Adult
(22)
Male
(20)
Middle Aged
(17)
Psoriasis - Immunology
(16)
Allergy And Immunology
(15)
Gene Expression
(15)
Psoriasis
(15)
Psoriasis - Pathology
(15)
Skin
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Skin - Immunology
(14)
Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response

Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities

Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis

IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model

TNF-α Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-α Antagonists to Improve Skin Barrier

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology

Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes

The Human Cutaneous Squamous Cell Carcinoma Microenvironment Is Characterized by Increased Lymphatic Density and Enhanced Expression of Macrophage-Derived VEGF-C

TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques

Increase in TNF-α and Inducible Nitric Oxide Synthase-Expressing Dendritic Cells in Psoriasis and Reduction with Efalizumab (Anti-CD11a)

Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets

Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis

Alefacept Reduces Infiltrating T Cells, Activated Dendritic Cells, and Inflammatory Genes in Psoriasis Vulgaris

Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects

Atopic dermatitis keratinocytes exhibit normal TH17 cytokine responses

Effects of Etanercept Are Distinct from Infliximab in Modulating Proinflammatory Genes in Activated Human Leukocytes

Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

Suchergebnisse filtern